Pertussis vaccines — 1993

This publication has 28 references indexed in Scilit:

• Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance
  Vaccine, 1992
• Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: Safety and immunogenicity in 12- to 24- and 2- to 4-month-old children
  The Journal of Pediatrics, 1992
• Specific immunoglobulin for treatment of whooping cough
  The Lancet, 1991
• Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa
  Vaccine, 1991
• Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis.
  The Journal of Experimental Medicine, 1989
• Progress in worldwide control and elimination of disease through immunization
  The Journal of Pediatrics, 1989
• Human Serum Antibody Responses to Bordetella pertussis Infection and Pertussis Vaccination
  The Journal of Infectious Diseases, 1989
• PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN—PROTECIVE EFFICACY AND ADVERSE EVENTS
  The Lancet, 1988
• Reflections on the Efficacy of Pertussis Vaccines
  Clinical Infectious Diseases, 1987
• Efficacy of an acellular pertussis vaccine in Japan
  The Journal of Pediatrics, 1985